In part 4 of this video interview, Rama Kondru, PhD, CEO of Veridix AI discusses best practices for choosing the right artificial intelligence solutions.
When vendors are evaluating which artificial intelligence (AI) solutions are best for them, what should they be keeping top of mind?
Kondru: It's a great question. There's a lot of companies that are popping up in the AI space with LLMs (large language models). The factors that one needs to think about is performance and reliability. The second one is, do they have built-in guardrails to ensure data integrity and patient safety within the life sciences sector? AI has a different meaning for our participants and folks across the globe, and having this keen eye on the guardrails for data integrity and patient safety is a must. Some of the considerations that I would include when I'm looking at a vendor race, are there business goals aligned? For us, I think in the end, we serve the participants and the patients, and our hope is to impact human health, so is there a business alignment there? How is the data infrastructure? Are there any safeguards or guardrails around patient data privacy? We also want to make sure that there are ethical considerations. We talked about patient recruitment and site selection—are there inherent biases? Is there fairness, transparency, and accountability? These are some of the things that I would look at when I'm picking out a vendor in the AI space or LLM space.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
SCOPE Summit 2025: Enhancing the Patient Experience Through Site Centricity
February 12th 2025In an interview with ACT senior editor Andy Studna at SCOPE Summit, Ashley Davidson, vice president, product lead - sponsor tech strategy, Advarra, highlights the need for more site-centric approaches in study startup.